Search Results - "Transou, Andrea"
-
1
Sox2 Promotes Malignancy in Glioblastoma by Regulating Plasticity and Astrocytic Differentiation
Published in Neoplasia (New York, N.Y.) (01-03-2014)“…Abstract The high-mobility group–box transcription factor sex-determining region Y–box 2 (Sox2) is essential for the maintenance of stem cells from early…”
Get full text
Journal Article -
2
Optimization of Glioblastoma Mouse Orthotopic Xenograft Models for Translational Research
Published in Comparative medicine (01-08-2017)“…Glioblastoma is an aggressive primary brain tumor predominantly localized to the cerebral cortex. We developed a panel of patient-derived mouse orthotopic…”
Get full text
Journal Article -
3
Optimization of high grade glioma cell culture from surgical specimens for use in clinically relevant animal models and 3D immunochemistry
Published in Journal of visualized experiments (07-01-2014)“…Glioblastomas, the most common and aggressive form of astrocytoma, are refractory to therapy, and molecularly heterogeneous. The ability to establish cell…”
Get full text
Journal Article -
4
Anaplastic meningioma: octreotide therapy for a case of recurrent and progressive intracranial disease
Published in Journal of neurosurgery (01-02-2016)“…Meningiomas are common intracranial tumors categorized as Grades I-III per the current WHO guidelines. A small percentage of meningiomas are Grades II and III,…”
Get full text
Journal Article -
5
CSIG-10. PLATELET-DERIVED GROWTH FACTOR RECEPTOR ALPHA ONCOGENE DEPENDENCY IN GLIOBLASTOMA
Published in Neuro-oncology (Charlottesville, Va.) (12-11-2021)“…Abstract PDGFRA is the second most frequently amplified gene encoding receptor tyrosine kinase in adult glioblastoma (GBM), oftentimes as extrachromosomal…”
Get full text
Journal Article -
6
CSIG-06. PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA AS AN ONCOGENIC DRIVER IN GLIOBLASTOMA
Published in Neuro-oncology (Charlottesville, Va.) (09-11-2020)“…Abstract Activated platelet derived growth factor receptor alpha (PDGFRα) is essential for the maintenance of oligodendrocyte progenitors. Differential…”
Get full text
Journal Article -
7
Abstract 1505: Platelet derived growth factor receptor alpha oncogene dependency in glioblastoma
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Abstract Platelet-derived growth factor receptor alpha (PDGFRA) is a ligand-activated receptor tyrosine kinase (RTK) involved in neurodevelopment. In pediatric…”
Get full text
Journal Article -
8
Abstract 2519: Identification of novel MET fusion transcript amplification in glioblastoma
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Glioblastoma (GBM) is the most common and aggressive primary CNS malignant tumor with a 15.2% 2 year survival rate for tumors diagnosed between 2008…”
Get full text
Journal Article -
9
The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen
Published in Cancer research (Chicago, Ill.) (04-03-2024)“…Tumor adaptation or selection is thought to underlie therapy resistance in glioma. To investigate longitudinal epigenetic evolution of gliomas in response to…”
Get full text
Journal Article -
10
Detection of diagnostic and prognostic methylation-based signatures in liquid biopsy specimens from patients with meningiomas
Published in Nature communications (13-09-2023)“…Recurrence of meningiomas is unpredictable by current invasive methods based on surgically removed specimens. Identification of patients likely to recur using…”
Get full text
Journal Article -
11
TMOD-06. HIGH INCIDENCE OF TUMORS AFTER TREATMENT WITH A DNA-ALKYLATING AGENT IN MOUSE STRAINS COMMONLY USED IN PRE-CLINICAL STUDIES
Published in Neuro-oncology (Charlottesville, Va.) (05-11-2018)“…Abstract Glioblastoma (GBM) is commonly treated with the DNA-alkylating agent temozolomide (TMZ). Silencing O6-methylguanine-DNA methyltransferase (MGMT) by…”
Get full text
Journal Article -
12
Abstract 3491: Heterogeneous extrachromosomal amplification of mutant PDGFRA is associated with an aggressive phenotype in glioblastoma
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Background & Objective: Receptor tyrosine kinase (RTK) signaling is altered in over 80% of glioblastoma (GBM) cases, frequently through gene…”
Get full text
Journal Article -
13
SAT587 Methylation-based Machine Learning Classifiers Discriminate Sellar Tumors By Lobe Origin Using Liquid Biopsy Or Surgical Specimens
Published in Journal of the Endocrine Society (05-10-2023)“…Abstract Disclosure: G.A. Herrgott: None. K.P. Asmaro: None. M. Wells: None. K. Nelson: None. B. Thomas: None. L.A. Hasselbach: None. A. Transou: None. S…”
Get full text
Journal Article -
14
Sox2 Promotes Malignancy in Glioblastoma by Regulating Plasticity and Astrocytic Differentiation12
Published in Neoplasia (New York, N.Y.) (13-04-2014)“…The high-mobility group–box transcription factor sex-determining region Y–box 2 (Sox2) is essential for the maintenance of stem cells from early development to…”
Get full text
Journal Article -
15